Disclaimer: We aren’t paid by companies to write analysis on Trading For Millions ― it’s 100% independent. We also aren’t licensed to provide financial advice on the blog. Trading For Millions analyses companies we own for fun ― and it’s mostly biased. You should consider your own financial position and perform research on any company detailed on Trading For Millions.
Finally, if you want to share our research, please link to our website to help us grow.
Future Plans for Trading For Millions and the Latest Analysis on our Main Deep Value Play
Impression Healthcare (ASX:IHL) has been quiet lately, which is why we haven’t written much. But it remains our favourite deep value play. This shouldn’t shock you. We wrote about the company at length, here (7 March) and here (25 March). These two updates remain highly relevant and explain the core investment thesis, which we will build on today.
Prior to sharing our thoughts on the company’s latest quarterly report, we want to update you on our plans for Trading For Millions over the coming months.
Future Plans for Trading For Millions
Trading For Millions is different from everything else on the internet ― we want to teach you how to trade like a professional. In this case, while we invest our own capital into each company previewed on the blog, we’re in the process of writing trading course for FREE.
The FREE five-part trading course should be live by mid-year (we plan to get it out ASAP). The goal of the course is to help you think like a professional trader. With this power and knowhow, your portfolio should see better returns in the short, medium and long term.
Trading For Millions also plans to add more deep value investment opportunities on the blog. But we won’t add more deep value plays until Impression Healthcare delivers as intended. There’s no point writing about other opportunities ― we want to demonstrate our abilities. We also write this blog for fun and don’t need to churn and burn content for money.
When the timing is right, we will take partial gains on Impression Healthcare (we will let you know when this happens) and analyse another deep value play on Trading For Millions.
That time isn’t now.
Impression Healthcare’s register has been cleaned up and the overall business is progressing in the right direction. That’s what you want as a deep value investor at this stage of the game. In our view, the company offers significant potential from current share prices ― especially considering our analysis of the latest quarterly (more details below).
Remember, as communicated previously, we believe that Impression Healthcare is worth ― at least ― 5 cents per share in the short term. That’s our bare minimum target, mind you. It would give the company a market capitalisation of roughly $25 million. Ultimately, we see the share price moving towards 10 cents-plus when everything comes together. Hopefully that move starts playing out in the second half of the year, assuming the stock market holds up.
More deep value investments are coming…
In this case, while we eventually plan to rotate some capital into another deep value play to make the blog more active and interesting, we won’t stop following Impression Healthcare anytime soon. The company could become a titan of the medical cannabis (‘MedCan’) sector, which no one believes right now.
Deep value investing aside, we plan to preview more short-term position trades on Trading For Millions. On this note, while we’re still thinking how to structure this side of the blog (it could be a weekly post or something more concrete), we expect this platform will revolutionise the internet.
Let alone tracking their own medium-term trades (i.e. what we’re doing now), no one provides detailed short-term trades in real time. That’s because there are more frauds and fakes on the internet than real traders and investors.
To sum things up, while covering our main deep value play, our immediate focus is delivering a FREE trading course to amplify your trading performance. Secondly, given our overall mission for the blog, we plan to add more deep value opportunities on Trading For Millions. Lastly, while we remain unsure how to engage with the position trade portfolio, we have plans to beef up the blog with some short-term trading opportunities in the future.
Indeed,with plenty to look forward to in the months ahead, let’s turn our attention to the latest quarterly update for Impression Healthcare…
Position update on Impression Healthcare
First, we’ll provide an update of our position in the company. Foundation readers know we have plenty of skin in the game, across multiple accounts. We wouldn’t write such a high volume of analysis on Impression Healthcare if this wasn’t the case. Here’s an initial position from a smaller account to show our confidence level (dated 2 April 2019):
One analyst originally bought close to $50,000 in the company ― around current prices. That might not seem like much of an investment. And, while we hold significantly more shares across other accounts, the number is held in a nominee account for privacy purposes. Moreover, disclosing what we own makes us different from everyone else on the internet.
Standard disclaimer: Do your own research
The goal is to build a small amount of money into something much more substantial. Hopefully, the name of the blog ― Trading For Millions ― becomes a self-fulfilling prophecy over time. We put our money where our mouth is and don’t publish junk on the website.
We also don’t get paid by companies to write research ― everything is 100% independent on Trading For Millions. The incentive is to make good money buying the right stocks, get the story out, and hopefully teach you a thing or two about deep value investing.
Sure, some people will say we’re selling into every rally with our other accounts ― we own a lot of shares, after all. This could be true ― anything is possible. But the blog won’t grow on the back of poor stock write-ups. It will only grow by buying good companies with potential, where you can see the story play out in real time.
The goal is to hit multiple home runs at Trading For Millions. We believe Impression Healthcare, for example, will be the start of a tremendous track record in the months and years ahead.
Aside from possible conflicted intentions stated above, we’re not in the business of providing formal stock recommendations or financial advice on Trading For Millions. If you want to know when to buy or sell a company, you’ve come to the wrong place. We don’t have a financial licence and, as stated earlier, write this blog merely for fun.
That might change one day.
But not anytime soon.
Trading For Millions is a hobby blog.
You should perform your own research on each company profiled on Trading For Millions. Our analysis is skewed to the positive side, as we hold a large amount of shares in each company profiled on the website. We’re happy to invest a large amount of money in companies we believe could return five to 10 times our original investment (nominal amount shown in the table above).
The large target might sound ridiculous.
But this is deep value investing. The goal is to buy into turnaround stories before they happen, writing about them in real time. In this case, given our collective experience, we are happy to stake our original reputation on Impression Healthcare today. Trading For Millions will track the company’s journey and will disclose whether we sell any shares going forward.
Let’s analyse the company’s latest quarterly…